Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1S)-2-{[{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(pentanoyloxy)methyl]ethyl octanoate is a synthetic phosphatidylglycerol derivative belonging to the class of glycerophosphoglycerols. It is an experimental small molecule compound with a molecular formula of C19H36O10P and a molecular weight of approximately 455.46 g/mol. This compound structurally mimics natural phospholipids found in biological membranes but features pentanoyl and octanoyl ester groups instead of the longer-chain fatty acids typical in endogenous phosphatidylglycerols. Its mechanism of action and pharmacological properties have not been described in detail in public databases; it is primarily referenced as an experimental or research chemical[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1S)-2-{[{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(pentanoyloxy)methyl]ethyl octanoate.